Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, Inozyme Pharma (INZY) has a market cap of $59.069 million USD. According to our data, Inozyme Pharma is ranked No.7956 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $59.07 M |
-66.81%
|
| Dec 31, 2024 | $0.18 B |
-34.98%
|
| Dec 29, 2023 | $0.27 B |
305.71%
|
| Dec 30, 2022 | $67.45 M |
-84.60%
|
| Dec 31, 2021 | $0.44 B |
-66.96%
|
| Dec 31, 2020 | $1.33 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$149.09 B |
0.124 B
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
USA
|
 Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.26 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.75 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.16 B |
-0.989 M
|
USA
|
 bluebird bio
BLUE
|
$40.53 M |
0.000 M
|
USA
|
 Moderna
MRNA
|
$9.56 B |
-0.000 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$30.36 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
USA
|
| Market Cap | = | INZY Stock Price | * | INZY Shares Outstanding |
| = | $0.92 | * | 64.24 M | |
| = | $59.07 M |